|
1
|
Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
|
J Biol Chem
|
2002
|
1.95
|
|
2
|
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
|
Mol Cancer Res
|
2006
|
1.69
|
|
3
|
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
|
Prostate
|
2007
|
1.37
|
|
4
|
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
|
Mol Cancer Res
|
2008
|
1.18
|
|
5
|
Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
|
Prostate
|
2010
|
1.08
|
|
6
|
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
|
Prostate
|
2009
|
1.06
|
|
7
|
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
|
J Innate Immun
|
2011
|
1.06
|
|
8
|
Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
|
Histopathology
|
2011
|
0.99
|
|
9
|
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells.
|
Breast Cancer Res Treat
|
2011
|
0.98
|
|
10
|
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.
|
J Innate Immun
|
2008
|
0.98
|
|
11
|
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.98
|
|
12
|
Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
|
Clin Exp Metastasis
|
2004
|
0.98
|
|
13
|
Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion.
|
APMIS
|
2012
|
0.98
|
|
14
|
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.
|
J Exp Clin Cancer Res
|
2011
|
0.98
|
|
15
|
Bisphosphonates inhibit the growth of mesothelioma cells in vitro and in vivo.
|
Clin Cancer Res
|
2006
|
0.92
|
|
16
|
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells.
|
Breast Cancer Res Treat
|
2013
|
0.87
|
|
17
|
Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
|
Eur J Pharmacol
|
2007
|
0.87
|
|
18
|
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer.
|
Oncol Lett
|
2013
|
0.86
|
|
19
|
Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition.
|
Breast Cancer Res Treat
|
2003
|
0.83
|
|
20
|
Tumor necrosis factor-alpha induces interleukin-6 production via extracellular-regulated kinase 1 activation in breast cancer cells.
|
Breast Cancer Res Treat
|
2003
|
0.81
|
|
21
|
Chloroquine has tumor-inhibitory and tumor-promoting effects in triple-negative breast cancer.
|
Oncol Lett
|
2013
|
0.78
|
|
22
|
Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells.
|
Eur J Pharmacol
|
2006
|
0.77
|